/ /

Dr Erik L. Mertens

Erik L. Mertens, MD, FEBO is Director and Ophthalmic Surgeon at the Antwerp Eye Centre in Belgium. He may be reached by E-mail: [email protected]

Dr Mertens serves as a member of Ophthalmology Times Europe's Editorial Advisory Board.

Testing at point of care for improved patient satisfaction, re-treatment rates
After spending a few months testing for dry eye and treating the tear film before doing preoperative measurements, the re-treatment rate dropped from 11% to 3%.
Flapless procedure corrects presbyopia
Intrastromal treatment optimal for patients with mild hyperopia, has strict indications
Eyes front
2009 heralded more interesting developments for ophthalmology. OTEurope asked some of Europe's leading key opinion leaders for their thoughts on the news and developments that generated most excitement or had most significance in the Cataract & Refractive sector
Integrating phakic IOLs in a private practice
The implantation of IOLs in the eye has been part of cataract surgery practice for many years; however, it is only in more recent years that these implants have become available for refractive correction. To date, the resulting vision outcomes have been impressive. In fact, most refractive surgeons believe phakic IOLs will become the procedure of choice for certain forms of refractive correction. Because patients are wary of the perceived invasive nature of this procedure, however, phakic IOLs still have a long way to go in the race to gain patient popularity and trust.